<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34435242</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>02</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2509-9280</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Aug</Month><Day>26</Day></PubDate></JournalIssue><Title>European radiology experimental</Title><ISOAbbreviation>Eur Radiol Exp</ISOAbbreviation></Journal><ArticleTitle>Studying Alzheimer disease, Parkinson disease, and amyotrophic lateral sclerosis with 7-T magnetic resonance.</ArticleTitle><Pagination><StartPage>36</StartPage><MedlinePgn>36</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">36</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s41747-021-00221-5</ELocationID><Abstract><AbstractText>Ultra-high-field (UHF) magnetic resonance (MR) scanners, that is, equipment operating at static magnetic field of 7 tesla (7 T) and above, enable the acquisition of data with greatly improved signal-to-noise ratio with respect to conventional MR systems (e.g., scanners operating at 1.5 T and 3 T). The change in tissue relaxation times at UHF offers the opportunity to improve tissue contrast and depict features that were previously inaccessible. These potential advantages come, however, at a cost: in the majority of UHF-MR clinical protocols, potential drawbacks may include signal inhomogeneity, geometrical distortions, artifacts introduced by patient respiration, cardiac cycle, and motion. This article reviews the 7 T MR literature reporting the recent studies on the most widespread neurodegenerative diseases: Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>D&#xfc;zel</LastName><ForeName>Emrah</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Otto-von-Guericke University Magdeburg, Magdeburg, Germany. emrah.duezel@dzne.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany. emrah.duezel@dzne.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University College London, London, UK. emrah.duezel@dzne.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costagli</LastName><ForeName>Mauro</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>IRCCS Stella Maris, Pisa, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Genoa, Genova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donatelli</LastName><ForeName>Graziella</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Fondazione Imago 7, Pisa, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Speck</LastName><ForeName>Oliver</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Otto-von-Guericke University Magdeburg, Magdeburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cosottini</LastName><ForeName>Mirco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur Radiol Exp</MedlineTA><NlmUniqueID>101721752</NlmUniqueID><ISSNLinking>2509-9280</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009682" MajorTopicYN="N">Magnetic Resonance Spectroscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer disease</Keyword><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Magnetic resonance imaging</Keyword><Keyword MajorTopicYN="N">Neurodegenerative diseases</Keyword><Keyword MajorTopicYN="N">Parkinson disease</Keyword></KeywordList><CoiStatement>All authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>26</Day><Hour>6</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34435242</ArticleId><ArticleId IdType="pmc">PMC8387546</ArticleId><ArticleId IdType="doi">10.1186/s41747-021-00221-5</ArticleId><ArticleId IdType="pii">10.1186/s41747-021-00221-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Moser E, Stahlberg F, Ladd ME, Trattnig S. 7-T MR-from research to clinical applications? NMR Biomed. 2012;25:695&#x2013;716. doi: 10.1002/nbm.1794.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nbm.1794</ArticleId><ArticleId IdType="pubmed">22102481</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C, Li W, Tong KA, Yeom KW, Kuzminski S. Susceptibility-weighted imaging and quantitative susceptibility mapping in the brain. J Magn Reson Imaging. 2015;42:23&#x2013;41. doi: 10.1002/jmri.24768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmri.24768</ArticleId><ArticleId IdType="pmc">PMC4406874</ArticleId><ArticleId IdType="pubmed">25270052</ArticleId></ArticleIdList></Reference><Reference><Citation>Yacoub E, Harel N, U&#x1e7;urbil K. High-field fMRI unveils orientation columns in humans. Proc Natl Acad Sci U S A. 2008;105:10607&#x2013;10612. doi: 10.1073/pnas.0804110105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0804110105</ArticleId><ArticleId IdType="pmc">PMC2492463</ArticleId><ArticleId IdType="pubmed">18641121</ArticleId></ArticleIdList></Reference><Reference><Citation>Fracasso A, Luijten PR, Dumoulin SO, Petridou N. Laminar imaging of positive and negative BOLD in human visual cortex at 7 T. Neuroimage. 2017;164:100&#x2013;111. doi: 10.1016/j.neuroimage.2017.02.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2017.02.038</ArticleId><ArticleId IdType="pubmed">28213112</ArticleId></ArticleIdList></Reference><Reference><Citation>Ojemann JG, Akbudak E, Snyder AZ, McKinstry RC, Raichle ME, Conturo TE. Anatomic localization and quantitative analysis of gradient refocused echo-planar fMRI susceptibility artifacts. Neuroimage. 1997;6:156&#x2013;167. doi: 10.1006/nimg.1997.0289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nimg.1997.0289</ArticleId><ArticleId IdType="pubmed">9344820</ArticleId></ArticleIdList></Reference><Reference><Citation>Triantafyllou C, Hoge RD, Krueger G, et al. Comparison of physiological noise at 1.5 T, 3 T and 7 T and optimization of fMRI acquisition parameters. Neuroimage. 2005;26:243&#x2013;250. doi: 10.1016/j.neuroimage.2005.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2005.01.007</ArticleId><ArticleId IdType="pubmed">15862224</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaitsev M, Maclaren J, Herbst M. Motion artifacts in MRI: a complex problem with many partial solutions. J Magn Reson Imaging. 2015;42:887&#x2013;901. doi: 10.1002/jmri.24850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmri.24850</ArticleId><ArticleId IdType="pmc">PMC4517972</ArticleId><ArticleId IdType="pubmed">25630632</ArticleId></ArticleIdList></Reference><Reference><Citation>Jezzard P, Clare S. Sources of distortion in functional MRI data. Hum Brain Mapp. 1999;8:80&#x2013;85. doi: 10.1002/(SICI)1097-0193(1999)8:2/3&lt;80::AID-HBM2&gt;3.0.CO;2-C.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-0193(1999)8:2/3&lt;80::AID-HBM2&gt;3.0.CO;2-C</ArticleId><ArticleId IdType="pmc">PMC6873315</ArticleId><ArticleId IdType="pubmed">10524596</ArticleId></ArticleIdList></Reference><Reference><Citation>Gras V, Boland M, Vignaud A, et al. Homogeneous non-selective and slice-selective parallel-transmit excitations at 7 Tesla with universal pulses: a validation study on two commercial RF coils. PLoS One. 2017;12:e0183562. doi: 10.1371/journal.pone.0183562.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0183562</ArticleId><ArticleId IdType="pmc">PMC5565195</ArticleId><ArticleId IdType="pubmed">28827835</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladd ME, Bachert P, Meyerspeer M, et al. Pros and cons of ultra-high-field MRI/MRS for human application. Prog Nucl Magn Reson Spectrosc. 2018;109:1&#x2013;50. doi: 10.1016/j.pnmrs.2018.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pnmrs.2018.06.001</ArticleId><ArticleId IdType="pubmed">30527132</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack CR, Bennett DA, Blennow K, et al. NIA-AA research framework: toward a biological definition of Alzheimer&#x2019;s disease. Alzheimers Dement. 2018;14:535&#x2013;562. doi: 10.1016/j.jalz.2018.02.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2018.02.018</ArticleId><ArticleId IdType="pmc">PMC5958625</ArticleId><ArticleId IdType="pubmed">29653606</ArticleId></ArticleIdList></Reference><Reference><Citation>Young PNE, Estarellas M, Coomans E, et al. Imaging biomarkers in neurodegeneration: current and future practices. Alzheimers Res Ther. 2020;12:49. doi: 10.1186/s13195-020-00612-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-020-00612-7</ArticleId><ArticleId IdType="pmc">PMC7187531</ArticleId><ArticleId IdType="pubmed">32340618</ArticleId></ArticleIdList></Reference><Reference><Citation>Committee for Medicinal Products for Human Use (CHMP) (2011) Qualification opinion of low hippocampal volume (atrophy) by MRI for use in clinical trials for regulatory purpose-in pre-dementia stage of Alzheimer&#x2019;s disease</Citation></Reference><Reference><Citation>Hill DLG, Schwarz AJ, Isaac M, et al. Coalition Against Major Diseases/European Medicines Agency biomarker qualification of hippocampal volume for enrichment of clinical trials in predementia stages of Alzheimer&#x2019;s disease. Alzheimers Dement. 2014;10:421&#x2013;429.e3. doi: 10.1016/j.jalz.2013.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2013.07.003</ArticleId><ArticleId IdType="pubmed">24985687</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohrer JD, Nicholas JM, Cash DM, et al. Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis. Lancet Neurol. 2015;14:253&#x2013;262. doi: 10.1016/S1474-4422(14)70324-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70324-2</ArticleId><ArticleId IdType="pmc">PMC6742501</ArticleId><ArticleId IdType="pubmed">25662776</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack CR, Barnes J, Bernstein MA, et al. Magnetic resonance imaging in Alzheimer&#x2019;s disease neuroimaging initiative 2. Alzheimers Dement. 2015;11:740&#x2013;756. doi: 10.1016/j.jalz.2015.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2015.05.002</ArticleId><ArticleId IdType="pmc">PMC4523217</ArticleId><ArticleId IdType="pubmed">26194310</ArticleId></ArticleIdList></Reference><Reference><Citation>Wisse LEM, Ch&#xe9;telat G, Daugherty AM, et al. Hippocampal subfield volumetry from structural isotropic 1 mm3 MRI scans: a note of caution. Hum Brain Mapp. 2020;42:539&#x2013;550. doi: 10.1002/hbm.25234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hbm.25234</ArticleId><ArticleId IdType="pmc">PMC7775994</ArticleId><ArticleId IdType="pubmed">33058385</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xfc;zel E, Acosta-Cabronero J, Berron D, et al. European Ultrahigh-Field Imaging Network for Neurodegenerative Diseases (EUFIND) Alzheimers Dement Diagn Assess Dis Monit. 2019;11:538&#x2013;549.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6675944</ArticleId><ArticleId IdType="pubmed">31388558</ArticleId></ArticleIdList></Reference><Reference><Citation>Berron D, Vieweg P, Hochkeppler A, et al. A protocol for manual segmentation of medial temporal lobe subregions in 7 Tesla MRI. Neuroimage Clin. 2017;15:466&#x2013;482. doi: 10.1016/j.nicl.2017.05.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2017.05.022</ArticleId><ArticleId IdType="pmc">PMC5476466</ArticleId><ArticleId IdType="pubmed">28652965</ArticleId></ArticleIdList></Reference><Reference><Citation>Maass A, Berron D, Libby LA, Ranganath C, D&#xfc;zel E. Functional subregions of the human entorhinal cortex. Elife. 2015;4:1&#x2013;20. doi: 10.7554/eLife.06426.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.06426</ArticleId><ArticleId IdType="pmc">PMC4458841</ArticleId><ArticleId IdType="pubmed">26052749</ArticleId></ArticleIdList></Reference><Reference><Citation>Maass A, Berron D, Harrison TM, et al. Alzheimer&#x2019;s pathology targets distinct memory networks in the ageing brain. Brain. 2019;142:2492&#x2013;2509. doi: 10.1093/brain/awz154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz154</ArticleId><ArticleId IdType="pmc">PMC6658874</ArticleId><ArticleId IdType="pubmed">31199481</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Del Tredici K. The preclinical phase of the pathological process underlying sporadic Alzheimer&#x2019;s disease. Brain. 2015;138:2814&#x2013;2833. doi: 10.1093/brain/awv236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awv236</ArticleId><ArticleId IdType="pubmed">26283673</ArticleId></ArticleIdList></Reference><Reference><Citation>Berron D, van Westen D, Ossenkoppele R, Strandberg O, Hansson O. Medial temporal lobe connectivity and its associations with cognition in early Alzheimer&#x2019;s disease. Brain. 2020;143:1233&#x2013;1248. doi: 10.1093/brain/awaa068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa068</ArticleId><ArticleId IdType="pmc">PMC7174043</ArticleId><ArticleId IdType="pubmed">32252068</ArticleId></ArticleIdList></Reference><Reference><Citation>de Flores R, Berron D, Ding SL, et al. Characterization of hippocampal subfields using ex vivo MRI and histology data: lessons for in vivo segmentation. Hippocampus. 2020;30:545&#x2013;564. doi: 10.1002/hipo.23172.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hipo.23172</ArticleId><ArticleId IdType="pmc">PMC7192771</ArticleId><ArticleId IdType="pubmed">31675165</ArticleId></ArticleIdList></Reference><Reference><Citation>Maclaren J, Herbst M, Speck O, Zaitsev M. Prospective motion correction in brain imaging: a review. Magn Reson Med. 2013;69:621&#x2013;636. doi: 10.1002/mrm.24314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.24314</ArticleId><ArticleId IdType="pubmed">22570274</ArticleId></ArticleIdList></Reference><Reference><Citation>Newton A, McGugin R, Gauthier I. International society for magnetic resonance in medicine. 2019. Behavioral correlates to laminar thickness within the cortex; p. 0338.</Citation></Reference><Reference><Citation>Kulason S, Tward DJ, Brown T, et al. Cortical thickness atrophy in the transentorhinal cortex in mild cognitive impairment. Neuroimage Clin. 2019;21:101617. doi: 10.1016/j.nicl.2018.101617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2018.101617</ArticleId><ArticleId IdType="pmc">PMC6412863</ArticleId><ArticleId IdType="pubmed">30552075</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuehn E, Sereno MI. Modelling the human cortex in three dimensions. Trends Cogn Sci. 2018;22:1073&#x2013;1075. doi: 10.1016/j.tics.2018.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tics.2018.08.010</ArticleId><ArticleId IdType="pubmed">30236490</ArticleId></ArticleIdList></Reference><Reference><Citation>Betts MJ, Kirilina E, Otaduy MCG, et al. Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases. Brain. 2019;142:2558&#x2013;2571. doi: 10.1093/brain/awz193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz193</ArticleId><ArticleId IdType="pmc">PMC6736046</ArticleId><ArticleId IdType="pubmed">31327002</ArticleId></ArticleIdList></Reference><Reference><Citation>Betts MJ, Cardenas-Blanco A, Kanowski M, et al. Locus coeruleus MRI contrast is reduced in Alzheimer&#x2019;s disease dementia and correlates with CSF A&#x3b2; levels. Alzheimers Dement Diagn Assess Dis Monit. 2019;11:281&#x2013;285.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6439222</ArticleId><ArticleId IdType="pubmed">30976648</ArticleId></ArticleIdList></Reference><Reference><Citation>Priovoulos N, Jacobs HIL, Ivanov D, Uluda&#x11f; K, Verhey FRJ, Poser BA. High-resolution in vivo imaging of human locus coeruleus by magnetization transfer MRI at 3 T and 7 T. Neuroimage. 2018;168:427&#x2013;436. doi: 10.1016/j.neuroimage.2017.07.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2017.07.045</ArticleId><ArticleId IdType="pubmed">28743460</ArticleId></ArticleIdList></Reference><Reference><Citation>Dichgans M. Dementia risk after transient ischaemic attack and stroke. Lancet Neurol. 2019;18:223&#x2013;225. doi: 10.1016/S1474-4422(18)30497-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30497-6</ArticleId><ArticleId IdType="pubmed">30784546</ArticleId></ArticleIdList></Reference><Reference><Citation>Salman RA-S, McGoohan K, Rodrigues M, Dichgans M. Dementia after stroke due to intracerebral haemorrhage. Lancet Neurol. 2016;15:779&#x2013;780. doi: 10.1016/S1474-4422(16)30092-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(16)30092-8</ArticleId><ArticleId IdType="pubmed">27302345</ArticleId></ArticleIdList></Reference><Reference><Citation>Conijn MMA, Geerlings MI, Biessels GJ, et al. Cerebral microbleeds on MR imaging: comparison between 1.5 and 7 T. AJNR Am J Neuroradiol. 2011;32:1043&#x2013;1049. doi: 10.3174/ajnr.A2450.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A2450</ArticleId><ArticleId IdType="pmc">PMC8013148</ArticleId><ArticleId IdType="pubmed">21546463</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuijf HJ, de Bresser J, Geerlings MI, et al. Efficient detection of cerebral microbleeds on 7.0t mr images using the radial symmetry transform. Neuroimage. 2012;59:2266&#x2013;2273. doi: 10.1016/j.neuroimage.2011.09.061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2011.09.061</ArticleId><ArticleId IdType="pubmed">21985903</ArticleId></ArticleIdList></Reference><Reference><Citation>Jouvent E, Poupon C, Gray F, et al. Intracortical infarcts in small vessel disease: a combined 7-T postmortem MRI and neuropathological case study in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Stroke. 2011;42:e27&#x2013;e30. doi: 10.1161/STROKEAHA.110.594218.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.110.594218</ArticleId><ArticleId IdType="pubmed">21293025</ArticleId></ArticleIdList></Reference><Reference><Citation>van Veluw SJ, Shih AY, Smith EE, et al. Detection, risk factors, and functional consequences of cerebral microinfarcts. Lancet Neurol. 2017;16:730&#x2013;740. doi: 10.1016/S1474-4422(17)30196-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30196-5</ArticleId><ArticleId IdType="pmc">PMC5861500</ArticleId><ArticleId IdType="pubmed">28716371</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouvy WH, Kuijf HJ, Zwanenburg JJM, et al. Abnormalities of cerebral deep medullary veins on 7 Tesla MRI in amnestic mild cognitive impairment and early Alzheimer&#x2019;s disease: a pilot study. J Alzheimers Dis. 2017;57:705&#x2013;710. doi: 10.3233/JAD-160952.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-160952</ArticleId><ArticleId IdType="pubmed">28282806</ArticleId></ArticleIdList></Reference><Reference><Citation>Geurts L, Biessels GJ, Luijten P, Zwanenburg J. Better and faster velocity pulsatility assessment in cerebral white matter perforating arteries with 7 T quantitative flow MRI through improved slice profile, acquisition scheme, and postprocessing. Magn Reson Med. 2018;79:1473&#x2013;1482. doi: 10.1002/mrm.26821.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.26821</ArticleId><ArticleId IdType="pmc">PMC5811780</ArticleId><ArticleId IdType="pubmed">28699211</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindenholz A, van der Kolk AG, Zwanenburg JJM, Hendrikse J. The use and pitfalls of intracranial vessel wall imaging: how we do it. Radiology. 2018;286:12&#x2013;28. doi: 10.1148/radiol.2017162096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2017162096</ArticleId><ArticleId IdType="pubmed">29261469</ArticleId></ArticleIdList></Reference><Reference><Citation>Zwanenburg JJM, van Osch MJP. Targeting cerebral small vessel disease with MRI. Stroke. 2017;48:3175&#x2013;3182. doi: 10.1161/STROKEAHA.117.016996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.117.016996</ArticleId><ArticleId IdType="pubmed">28970280</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouvy WH, Geurts LJ, Kuijf HJ, et al. Assessment of blood flow velocity and pulsatility in cerebral perforating arteries with 7-T quantitative flow MRI. NMR Biomed. 2016;29:1295&#x2013;1304. doi: 10.1002/nbm.3306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nbm.3306</ArticleId><ArticleId IdType="pmc">PMC5008170</ArticleId><ArticleId IdType="pubmed">25916399</ArticleId></ArticleIdList></Reference><Reference><Citation>Perosa V, Priester A, Ziegler G, et al. Hippocampal vascular reserve associated with cognitive performance and hippocampal volume. Brain. 2020;143:622&#x2013;634. doi: 10.1093/brain/awz383.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz383</ArticleId><ArticleId IdType="pmc">PMC7009470</ArticleId><ArticleId IdType="pubmed">31994699</ArticleId></ArticleIdList></Reference><Reference><Citation>Spallazzi M, Dobisch L, Becke A, et al. Hippocampal vascularization patterns: a high-resolution 7 Tesla time-of-flight magnetic resonance angiography study. Neuroimage Clin. 2019;21:101609. doi: 10.1016/j.nicl.2018.11.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2018.11.019</ArticleId><ArticleId IdType="pmc">PMC6413539</ArticleId><ArticleId IdType="pubmed">30581106</ArticleId></ArticleIdList></Reference><Reference><Citation>Jochems ACC, Blair GW, Stringer MS, et al. Relationship between venules and perivascular spaces in sporadic small vessel diseases. Stroke. 2020;51:1503&#x2013;1506. doi: 10.1161/STROKEAHA.120.029163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.120.029163</ArticleId><ArticleId IdType="pmc">PMC7185057</ArticleId><ArticleId IdType="pubmed">32264759</ArticleId></ArticleIdList></Reference><Reference><Citation>Francis F, Ballerini L, Wardlaw JM. Perivascular spaces and their associations with risk factors, clinical disorders and neuroimaging features: a systematic review and meta-analysis. Int J Stroke. 2019;14:359&#x2013;371. doi: 10.1177/1747493019830321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1747493019830321</ArticleId><ArticleId IdType="pubmed">30762496</ArticleId></ArticleIdList></Reference><Reference><Citation>Vald&#xe9;s Hern&#xe1;ndez MD, Ballerini L, Glatz A, et al. Perivascular spaces in the centrum semiovale at the beginning of the 8th decade of life: effect on cognition and associations with mineral deposition. Brain Imaging Behav. 2020;14:1865&#x2013;1875. doi: 10.1007/s11682-019-00128-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11682-019-00128-1</ArticleId><ArticleId IdType="pmc">PMC7572330</ArticleId><ArticleId IdType="pubmed">31250262</ArticleId></ArticleIdList></Reference><Reference><Citation>Wardlaw JM, Benveniste H, Nedergaard M, et al. Perivascular spaces in the brain: anatomy, physiology and pathology. Nat Rev Neurol. 2020;16:137&#x2013;153. doi: 10.1038/s41582-020-0312-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-0312-z</ArticleId><ArticleId IdType="pubmed">32094487</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattern H, Sciarra A, Godenschweger F, et al. Prospective motion correction enables highest resolution time-of-flight angiography at 7 T. Magn Reson Med. 2018;80:248&#x2013;258. doi: 10.1002/mrm.27033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.27033</ArticleId><ArticleId IdType="pmc">PMC5876090</ArticleId><ArticleId IdType="pubmed">29230871</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattern H, Sciarra A, L&#xfc;sebrink F, Acosta-Cabronero J, Speck O. Prospective motion correction improves high-resolution quantitative susceptibility mapping at 7 T. Magn Reson Med. 2019;81:1605&#x2013;1619. doi: 10.1002/mrm.27509.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.27509</ArticleId><ArticleId IdType="pubmed">30298692</ArticleId></ArticleIdList></Reference><Reference><Citation>Terry RD, Masliah E, Salmon DP, et al. Physical basis of cognitive alterations in alzheimer&#x2019;s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol. 1991;30:572&#x2013;580. doi: 10.1002/ana.410300410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410300410</ArticleId><ArticleId IdType="pubmed">1789684</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou L, McInnes J, Wierda K, et al. Tau association with synaptic vesicles causes presynaptic dysfunction. Nat Commun. 2017;8:15295. doi: 10.1038/ncomms15295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms15295</ArticleId><ArticleId IdType="pmc">PMC5437271</ArticleId><ArticleId IdType="pubmed">28492240</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoover BR, Reed MN, Su J, et al. Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron. 2010;68:1067&#x2013;1081. doi: 10.1016/j.neuron.2010.11.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.11.030</ArticleId><ArticleId IdType="pmc">PMC3026458</ArticleId><ArticleId IdType="pubmed">21172610</ArticleId></ArticleIdList></Reference><Reference><Citation>Menkes-Caspi N, Yamin HG, Kellner V, Spires-Jones TL, Cohen D, Stern EA. Pathological tau disrupts ongoing network activity. Neuron. 2015;85:959&#x2013;966. doi: 10.1016/j.neuron.2015.01.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.01.025</ArticleId><ArticleId IdType="pubmed">25704951</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xfc;zel E, Berron D, Sch&#xfc;tze H, et al. CSF total tau levels are associated with hippocampal novelty irrespective of hippocampal volume. Alzheimers Dement Diagn Assess Dis Monit. 2018;10:782&#x2013;790.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6280588</ArticleId><ArticleId IdType="pubmed">30555890</ArticleId></ArticleIdList></Reference><Reference><Citation>Selkoe DJ. Soluble oligomers of the amyloid &#x3b2;-protein impair synaptic plasticity and behavior. Behav Brain Res. 2008;192:106&#x2013;113. doi: 10.1016/j.bbr.2008.02.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2008.02.016</ArticleId><ArticleId IdType="pmc">PMC2601528</ArticleId><ArticleId IdType="pubmed">18359102</ArticleId></ArticleIdList></Reference><Reference><Citation>Mucke L, Selkoe DJ. Neurotoxicity of amyloid &#x3b2;-protein: synaptic and network dysfunction. Cold Spring Harb Perspect Med. 2012;2:a006338. doi: 10.1101/cshperspect.a006338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a006338</ArticleId><ArticleId IdType="pmc">PMC3385944</ArticleId><ArticleId IdType="pubmed">22762015</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmqvist S, Sch&#xf6;ll M, Strandberg O, et al. Earliest accumulation of &#x3b2;-amyloid occurs within the default-mode network and concurrently affects brain connectivity. Nat Commun. 2017;8:1214. doi: 10.1038/s41467-017-01150-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-01150-x</ArticleId><ArticleId IdType="pmc">PMC5663717</ArticleId><ArticleId IdType="pubmed">29089479</ArticleId></ArticleIdList></Reference><Reference><Citation>Pohmann R, Speck O, Scheffler K. Signal-to-noise ratio and MR tissue parameters in human brain imaging at 3, 7, and 9.4 tesla using current receive coil arrays. Magn Reson Med. 2016;75:801&#x2013;809. doi: 10.1002/mrm.25677.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.25677</ArticleId><ArticleId IdType="pubmed">25820458</ArticleId></ArticleIdList></Reference><Reference><Citation>Uluda&#x1e7; K, M&#xfc;ller-Bierl B, U&#x1e7;urbil K. An integrative model for neuronal activity-induced signal changes for gradient and spin echo functional imaging. Neuroimage. 2009;48:150&#x2013;165. doi: 10.1016/j.neuroimage.2009.05.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2009.05.051</ArticleId><ArticleId IdType="pubmed">19481163</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x160;i&#x161;kov&#xe1; Z, Justus D, Kaneko H, et al. Dendritic structural degeneration is functionally linked to cellular hyperexcitability in a mouse model of alzheimer&#x2019;s disease. Neuron. 2014;84:1023&#x2013;1033. doi: 10.1016/j.neuron.2014.10.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.10.024</ArticleId><ArticleId IdType="pubmed">25456500</ArticleId></ArticleIdList></Reference><Reference><Citation>Palop JJ, Mucke L. Network abnormalities and interneuron dysfunction in Alzheimer disease. Nat Rev Neurosci. 2016;17:777&#x2013;792. doi: 10.1038/nrn.2016.141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn.2016.141</ArticleId><ArticleId IdType="pmc">PMC8162106</ArticleId><ArticleId IdType="pubmed">27829687</ArticleId></ArticleIdList></Reference><Reference><Citation>Maass A, Lockhart SN, Harrison TM, et al. Entorhinal tau pathology, episodic memory decline, and neurodegeneration in aging. J Neurosci. 2018;38:530&#x2013;543. doi: 10.1523/JNEUROSCI.2028-17.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2028-17.2017</ArticleId><ArticleId IdType="pmc">PMC5777108</ArticleId><ArticleId IdType="pubmed">29192126</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith MA, Harris PLR, Sayre LM, Perry G. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci U S A. 1997;94:9866&#x2013;9868. doi: 10.1073/pnas.94.18.9866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.94.18.9866</ArticleId><ArticleId IdType="pmc">PMC23283</ArticleId><ArticleId IdType="pubmed">9275217</ArticleId></ArticleIdList></Reference><Reference><Citation>Sian-H&#xfc;lsmann J, Mandel S, Youdim MBH, Riederer P. The relevance of iron in the pathogenesis of Parkinson&#x2019;s disease. J Neurochem. 2011;118:939&#x2013;957. doi: 10.1111/j.1471-4159.2010.07132.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2010.07132.x</ArticleId><ArticleId IdType="pubmed">21138437</ArticleId></ArticleIdList></Reference><Reference><Citation>Lovejoy DB, Guillemin GJ. The potential for transition metal-mediated neurodegeneration in amyotrophic lateral sclerosis. Front Aging Neurosci. 2014;6:6. doi: 10.3389/fnagi.2014.00173.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2014.00173</ArticleId><ArticleId IdType="pmc">PMC4107949</ArticleId><ArticleId IdType="pubmed">25100994</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, Del Tredici K, Toledo JB, et al. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol. 2013;74:20&#x2013;38. doi: 10.1002/ana.23937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23937</ArticleId><ArticleId IdType="pmc">PMC3785076</ArticleId><ArticleId IdType="pubmed">23686809</ArticleId></ArticleIdList></Reference><Reference><Citation>McGeer PL, Itagaki S, Akiyama H, McGeer EG. Rate of cell death in parkinsonism indicates active neuropathological process. Ann Neurol. 1988;24:574&#x2013;576. doi: 10.1002/ana.410240415.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410240415</ArticleId><ArticleId IdType="pubmed">3239957</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwan JY, Jeong SY, Van Gelderen P, et al. Iron accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: correlating 7 tesla MRI and pathology. PLoS One. 2012;7:e35241. doi: 10.1371/journal.pone.0035241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0035241</ArticleId><ArticleId IdType="pmc">PMC3328441</ArticleId><ArticleId IdType="pubmed">22529995</ArticleId></ArticleIdList></Reference><Reference><Citation>Connor JR, Snyder BS, Beard JL, Fine RE, Mufson EJ. Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer&#x2019;s disease. J Neurosci Res. 1992;31:327&#x2013;335. doi: 10.1002/jnr.490310214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.490310214</ArticleId><ArticleId IdType="pubmed">1573683</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Liu T. Quantitative susceptibility mapping (QSM): decoding MRI data for a tissue magnetic biomarker. Magn Reson Med. 2015;73:82&#x2013;101. doi: 10.1002/mrm.25358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.25358</ArticleId><ArticleId IdType="pmc">PMC4297605</ArticleId><ArticleId IdType="pubmed">25044035</ArticleId></ArticleIdList></Reference><Reference><Citation>Daugherty AM, Haacke EM, Raz N. Striatal iron content predicts its shrinkage and changes in verbal working memory after two years in healthy adults. J Neurosci. 2015;35:6731&#x2013;6743. doi: 10.1523/JNEUROSCI.4717-14.2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4717-14.2015</ArticleId><ArticleId IdType="pmc">PMC4412893</ArticleId><ArticleId IdType="pubmed">25926451</ArticleId></ArticleIdList></Reference><Reference><Citation>Callaghan MF, Freund P, Draganski B, et al. Widespread age-related differences in the human brain microstructure revealed by quantitative magnetic resonance imaging. Neurobiol Aging. 2014;35:1862&#x2013;1872. doi: 10.1016/j.neurobiolaging.2014.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.02.008</ArticleId><ArticleId IdType="pmc">PMC4024196</ArticleId><ArticleId IdType="pubmed">24656835</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Wu B, Batrachenko A, et al. Differential developmental trajectories of magnetic susceptibility in human brain gray and white matter over the lifespan. Hum Brain Mapp. 2014;35:2698&#x2013;2713. doi: 10.1002/hbm.22360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hbm.22360</ArticleId><ArticleId IdType="pmc">PMC3954958</ArticleId><ArticleId IdType="pubmed">24038837</ArticleId></ArticleIdList></Reference><Reference><Citation>Betts MJ, Cardenas-Blanco A, Kanowski M, Jessen F, D&#xfc;zel E. In vivo MRI assessment of the human locus coeruleus along its rostrocaudal extent in young and older adults. Neuroimage. 2017;163:150&#x2013;159. doi: 10.1016/j.neuroimage.2017.09.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2017.09.042</ArticleId><ArticleId IdType="pubmed">28943414</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta-Cabronero J, Betts MJ, Cardenas-Blanco A, Yang S, Nestor PJ. In vivo MRI mapping of brain iron deposition across the adult lifespan. J Neurosci. 2016;36:364&#x2013;374. doi: 10.1523/JNEUROSCI.1907-15.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1907-15.2016</ArticleId><ArticleId IdType="pmc">PMC4710766</ArticleId><ArticleId IdType="pubmed">26758829</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta-Cabronero J, Williams GB, Cardenas-Blanco A, Arnold RJ, Lupson V, Nestor PJ. In vivo quantitative susceptibility mapping (QSM) in Alzheimer&#x2019;s disease. PLoS One. 2013;8:e81093. doi: 10.1371/journal.pone.0081093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0081093</ArticleId><ArticleId IdType="pmc">PMC3836742</ArticleId><ArticleId IdType="pubmed">24278382</ArticleId></ArticleIdList></Reference><Reference><Citation>van Bergen JMG, Li X, Quevenco FC, et al. Simultaneous quantitative susceptibility mapping and Flutemetamol-PET suggests local correlation of iron and &#x3b2;-amyloid as an indicator of cognitive performance at high age. Neuroimage. 2018;174:308&#x2013;316. doi: 10.1016/j.neuroimage.2018.03.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2018.03.021</ArticleId><ArticleId IdType="pmc">PMC5949258</ArticleId><ArticleId IdType="pubmed">29548847</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayton S, Fazlollahi A, Bourgeat P, et al. Cerebral quantitative susceptibility mapping predicts amyloid-&#x3b2;-related cognitive decline. Brain. 2017;140:2112&#x2013;2119. doi: 10.1093/brain/awx137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awx137</ArticleId><ArticleId IdType="pubmed">28899019</ArticleId></ArticleIdList></Reference><Reference><Citation>Bechten A, Wattjes MP, Purcell DD, et al. Validation of an MRI rating scale for amyloid-related imaging abnormalities. J Neuroimaging. 2017;27:318&#x2013;325. doi: 10.1111/jon.12422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jon.12422</ArticleId><ArticleId IdType="pubmed">28102639</ArticleId></ArticleIdList></Reference><Reference><Citation>Brashear HR, Ketter N, Bogert J, Di J, Salloway SP, Sperling R. Clinical evaluation of amyloid-related imaging abnormalities in bapineuzumab phase III studies. J Alzheimers Dis. 2018;66:1409&#x2013;1424. doi: 10.3233/JAD-180675.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-180675</ArticleId><ArticleId IdType="pubmed">30412493</ArticleId></ArticleIdList></Reference><Reference><Citation>Heuer E, Jacobs J, Du R, et al. Amyloid-related imaging abnormalities in an aged squirrel monkey with cerebral amyloid angiopathy. J Alzheimers Dis. 2017;57:519&#x2013;530. doi: 10.3233/JAD-160981.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-160981</ArticleId><ArticleId IdType="pmc">PMC5624788</ArticleId><ArticleId IdType="pubmed">28269776</ArticleId></ArticleIdList></Reference><Reference><Citation>Ketter N, Brashear HR, Bogert J, et al. Central review of amyloid-related imaging abnormalities in two phase III clinical trials of bapineuzumab in mild-to-moderate alzheimer&#x2019;s disease patients. J Alzheimers Dis. 2017;57:557&#x2013;573. doi: 10.3233/JAD-160216.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-160216</ArticleId><ArticleId IdType="pubmed">28269765</ArticleId></ArticleIdList></Reference><Reference><Citation>Martens RM, Bechten A, Ingala S, et al. The value of subtraction MRI in detection of amyloid-related imaging abnormalities with oedema or effusion in Alzheimer&#x2019;s patients: an interobserver study. Eur Radiol. 2018;28:1215&#x2013;1226. doi: 10.1007/s00330-017-5022-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00330-017-5022-6</ArticleId><ArticleId IdType="pmc">PMC5811582</ArticleId><ArticleId IdType="pubmed">28956123</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;ran P, Cherubini A, Assogna F, et al. Magnetic resonance imaging markers of Parkinson&#x2019;s disease nigrostriatal signature. Brain. 2010;133:3423&#x2013;3433. doi: 10.1093/brain/awq212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awq212</ArticleId><ArticleId IdType="pubmed">20736190</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutchinson M, Raff U, Lebedev S. MRI correlates of pathology in parkinsonism: segmented inversion recovery ratio imaging (SIRRIM) Neuroimage. 2003;20:1899&#x2013;1902. doi: 10.1016/j.neuroimage.2003.07.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2003.07.012</ArticleId><ArticleId IdType="pubmed">14642500</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin WRW, Wieler M, Gee M. Midbrain iron content in early Parkinson disease: a potential biomarker of disease status. Neurology. 2008;70:1411&#x2013;1417. doi: 10.1212/01.wnl.0000286384.31050.b5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000286384.31050.b5</ArticleId><ArticleId IdType="pubmed">18172063</ArticleId></ArticleIdList></Reference><Reference><Citation>Ordidge RJ, Gorell JM, Deniau JC, Knight RA, Helpern JA. Assessment of relative brain iron concentrations using T2-weighted and T2*-weighted MRI at 3 Tesla. Magn Reson Med. 1994;32:335&#x2013;341. doi: 10.1002/mrm.1910320309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.1910320309</ArticleId><ArticleId IdType="pubmed">7984066</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaillancourt DE, Prodoehl J, Abraham I, et al. High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease. Neurology. 2009;72:1378&#x2013;1384. doi: 10.1212/01.wnl.0000340982.01727.6e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000340982.01727.6e</ArticleId><ArticleId IdType="pmc">PMC2677508</ArticleId><ArticleId IdType="pubmed">19129507</ArticleId></ArticleIdList></Reference><Reference><Citation>Leh&#xe9;ricy S, Sharman MA, Dos Santos CL, et al. Magnetic resonance imaging of the substantia nigra in Parkinson&#x2019;s disease. Mov Disord. 2012;27:822&#x2013;830. doi: 10.1002/mds.25015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.25015</ArticleId><ArticleId IdType="pubmed">22649063</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirata FCC, Sato JR, Vieira G, et al. Substantia nigra fractional anisotropy is not a diagnostic biomarker of Parkinson&#x2019;s disease: a diagnostic performance study and meta-analysis. Eur Radiol. 2017;27:2640&#x2013;2648. doi: 10.1007/s00330-016-4611-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00330-016-4611-0</ArticleId><ArticleId IdType="pubmed">27709279</ArticleId></ArticleIdList></Reference><Reference><Citation>Sclocco R, Beissner F, Bianciardi M, Polimeni JR, Napadow V. Challenges and opportunities for brainstem neuroimaging with ultrahigh field MRI. Neuroimage. 2018;168:412&#x2013;426. doi: 10.1016/j.neuroimage.2017.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2017.02.052</ArticleId><ArticleId IdType="pmc">PMC5777900</ArticleId><ArticleId IdType="pubmed">28232189</ArticleId></ArticleIdList></Reference><Reference><Citation>Balchandani P, Naidich TP. Ultra-high-field MR neuroimaging. AJNR Am J Neuroradiol. 2015;36:1204&#x2013;1215. doi: 10.3174/ajnr.A4180.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A4180</ArticleId><ArticleId IdType="pmc">PMC4472608</ArticleId><ArticleId IdType="pubmed">25523591</ArticleId></ArticleIdList></Reference><Reference><Citation>Deistung A, Sch&#xe4;fer A, Schweser F, et al. High-resolution MR imaging of the human brainstem in vivo at 7 Tesla. Front Hum Neurosci. 2013;7:710. doi: 10.3389/fnhum.2013.00710.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnhum.2013.00710</ArticleId><ArticleId IdType="pmc">PMC3810670</ArticleId><ArticleId IdType="pubmed">24194710</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosottini M, Frosini D, Pesaresi I, et al. MR imaging of the substantia nigra at 7 T enables diagnosis of Parkinson disease. Radiology. 2014;271:831&#x2013;838. doi: 10.1148/radiol.14131448.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.14131448</ArticleId><ArticleId IdType="pubmed">24601752</ArticleId></ArticleIdList></Reference><Reference><Citation>Blazejewska AI, Schwarz ST, Pitiot A, et al. Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7 T MRI. Neurology. 2013;81:534&#x2013;540. doi: 10.1212/WNL.0b013e31829e6fd2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31829e6fd2</ArticleId><ArticleId IdType="pmc">PMC3775686</ArticleId><ArticleId IdType="pubmed">23843466</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon D-H, Kim J-M, Oh S-H, et al. Seven-tesla magnetic resonance images of the substantia nigra in Parkinson disease. Ann Neurol. 2012;71:267&#x2013;277. doi: 10.1002/ana.22592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22592</ArticleId><ArticleId IdType="pubmed">22367998</ArticleId></ArticleIdList></Reference><Reference><Citation>Damier P, Hirsch EC, Agid Y, Graybiel AM. The substantia nigra of the human brain. Brain. 1999;122:1421&#x2013;1436. doi: 10.1093/brain/122.8.1421.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/122.8.1421</ArticleId><ArticleId IdType="pubmed">10430829</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J-M, Jeong H-J, Bae YJ, et al. Loss of substantia nigra hyperintensity on 7 Tesla MRI of Parkinson&#x2019;s disease, multiple system atrophy, and progressive supranuclear palsy. Parkinsonism Relat Disord. 2016;26:47&#x2013;54. doi: 10.1016/j.parkreldis.2016.01.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2016.01.023</ArticleId><ArticleId IdType="pubmed">26951846</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarz ST, Afzal M, Morgan PS, Bajaj N, Gowland PA, Auer DP. The &#x201c;swallow tail&#x201d; appearance of the healthy nigrosome - a new accurate test of Parkinson&#x2019;s disease: a case-control and retrospective cross-sectional MRI study at 3 T. PLoS One. 2014;9:e93814. doi: 10.1371/journal.pone.0093814.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0093814</ArticleId><ArticleId IdType="pmc">PMC3977922</ArticleId><ArticleId IdType="pubmed">24710392</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt MA, Engelhorn T, Marxreiter F, et al. Ultra high-field SWI of the substantia nigra at 7 T: Reliability and consistency of the swallow-tail sign. BMC Neurol. 2017;17:194. doi: 10.1186/s12883-017-0975-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-017-0975-2</ArticleId><ArticleId IdType="pmc">PMC5658950</ArticleId><ArticleId IdType="pubmed">29073886</ArticleId></ArticleIdList></Reference><Reference><Citation>Damier P, Hirsch EC, Agid Y, Graybiel AM. The substantia nigra of the human brain. Brain. 1999;122:1437&#x2013;1448. doi: 10.1093/brain/122.8.1437.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/122.8.1437</ArticleId><ArticleId IdType="pubmed">10430830</ArticleId></ArticleIdList></Reference><Reference><Citation>Gramsch C, Reuter I, Kraff O, et al. Nigrosome 1 visibility at susceptibility weighted 7 T MRI&#x2014;A dependable diagnostic marker for Parkinson&#x2019;s disease or merely an inconsistent, age-dependent imaging finding? PLoS One. 2017;12:e0185489. doi: 10.1371/journal.pone.0185489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0185489</ArticleId><ArticleId IdType="pmc">PMC5634553</ArticleId><ArticleId IdType="pubmed">29016618</ArticleId></ArticleIdList></Reference><Reference><Citation>Duguid JR, De La Paz R, DeGroot J. Magnetic resonance imaging of the midbrain in Parkinson&#x2019;s disease. Ann Neurol. 1986;20:744&#x2013;747. doi: 10.1002/ana.410200618.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410200618</ArticleId><ArticleId IdType="pubmed">3813504</ArticleId></ArticleIdList></Reference><Reference><Citation>Massey L, Miranda M, Al-Helli O, et al. 9.4 T MR microscopy of the substantia nigra with pathological validation in controls and disease. NeuroImage Clin. 2017;13:154&#x2013;163. doi: 10.1016/j.nicl.2016.11.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2016.11.015</ArticleId><ArticleId IdType="pmc">PMC5144755</ArticleId><ArticleId IdType="pubmed">27981030</ArticleId></ArticleIdList></Reference><Reference><Citation>Noh Y, Sung YH, Lee J, Kim EY. Nigrosome 1 detection at 3 T MRI for the diagnosis of early-stage idiopathic Parkinson disease: assessment of diagnostic accuracy and agreement on imaging asymmetry and clinical laterality. AJNR Am J Neuroradiol. 2015;36:2010&#x2013;2016. doi: 10.3174/ajnr.A4412.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A4412</ArticleId><ArticleId IdType="pmc">PMC7964859</ArticleId><ArticleId IdType="pubmed">26294646</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehericy S, Vaillancourt DE, Seppi K, et al. The role of high-field magnetic resonance imaging in parkinsonian disorders: pushing the boundaries forward. Mov Disord. 2017;32:510&#x2013;525. doi: 10.1002/mds.26968.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.26968</ArticleId><ArticleId IdType="pubmed">28370449</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosottini M, Frosini D, Pesaresi I, et al. Comparison of 3 T and 7 T susceptibility-weighted angiography of the substantia nigra in diagnosing Parkinson disease. AJNR Am J Neuroradiol. 2015;36:461&#x2013;466. doi: 10.3174/ajnr.A4158.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A4158</ArticleId><ArticleId IdType="pmc">PMC8013050</ArticleId><ArticleId IdType="pubmed">25376811</ArticleId></ArticleIdList></Reference><Reference><Citation>Lotfipour AK, Wharton S, Schwarz ST, et al. High resolution magnetic susceptibility mapping of the substantia nigra in Parkinson&#x2019;s disease. J Magn Reson Imaging. 2012;35:48&#x2013;55. doi: 10.1002/jmri.22752.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmri.22752</ArticleId><ArticleId IdType="pubmed">21987471</ArticleId></ArticleIdList></Reference><Reference><Citation>Bae YJ, Kim J-M, Kim E, et al. Loss of nigral hyperintensity on 3 Tesla MRI of Parkinsonism: comparison with 123 I-FP-CIT SPECT. Mov Disord. 2016;31:684&#x2013;692. doi: 10.1002/mds.26584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.26584</ArticleId><ArticleId IdType="pubmed">26990970</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarz ST, Mougin O, Xing Y, et al. Parkinson&#x2019;s disease related signal change in the nigrosomes 1&#x2013;5 and the substantia nigra using T2* weighted 7 T MRI. Neuroimage Clin. 2018;19:683&#x2013;689. doi: 10.1016/j.nicl.2018.05.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2018.05.027</ArticleId><ArticleId IdType="pmc">PMC5986169</ArticleId><ArticleId IdType="pubmed">29872633</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceravolo R, Antonini A, Frosini D, et al. Nigral anatomy and striatal denervation in genetic Parkinsonism: a family report. Mov Disord. 2015;30:1148&#x2013;1149. doi: 10.1002/mds.26255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.26255</ArticleId><ArticleId IdType="pubmed">26095323</ArticleId></ArticleIdList></Reference><Reference><Citation>Frosini D, Cosottini M, Donatelli G, et al. Seven tesla MRI of the substantia nigra in patients with rapid eye movement sleep behavior disorder. Parkinsonism Relat Disord. 2017;43:105&#x2013;109. doi: 10.1016/j.parkreldis.2017.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2017.08.002</ArticleId><ArticleId IdType="pubmed">28781201</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber TR, Griffanti L, Bradley KM, et al. Nigrosome 1 imaging in REM sleep behavior disorder and its association with dopaminergic decline. Ann Clin Transl Neurol. 2020;7:26&#x2013;35. doi: 10.1002/acn3.50962.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.50962</ArticleId><ArticleId IdType="pmc">PMC6952317</ArticleId><ArticleId IdType="pubmed">31820587</ArticleId></ArticleIdList></Reference><Reference><Citation>Sung YH, Noh Y, Lee J, Kim EY. Drug-induced Parkinsonism versus idiopathic Parkinson disease: utility of Nigrosome 1 with 3-T Imaging. Radiology. 2016;279:849&#x2013;858. doi: 10.1148/radiol.2015151466.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2015151466</ArticleId><ArticleId IdType="pubmed">26690908</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez Akly MS, Stefani CV, Ciancaglini L, et al. Accuracy of nigrosome-1 detection to discriminate patients with Parkinson&#x2019;s disease and essential tremor. Neuroradiol J. 2019;32:395&#x2013;400. doi: 10.1177/1971400919853787.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1971400919853787</ArticleId><ArticleId IdType="pmc">PMC6856998</ArticleId><ArticleId IdType="pubmed">31149866</ArticleId></ArticleIdList></Reference><Reference><Citation>Tolosa E, Wenning G, Poewe W. The diagnosis of Parkinson&#x2019;s disease. Lancet Neurol. 2006;5:75&#x2013;86. doi: 10.1016/S1474-4422(05)70285-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(05)70285-4</ArticleId><ArticleId IdType="pubmed">16361025</ArticleId></ArticleIdList></Reference><Reference><Citation>Munoz E, Iranzo A, Rauek S, et al. Subclinical nigrostriatal dopaminergic denervation in the cerebellar subtype of multiple system atrophy (MSA-C) J Neurol. 2011;258:2248&#x2013;2253. doi: 10.1007/s00415-011-6108-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-011-6108-8</ArticleId><ArticleId IdType="pubmed">21633903</ArticleId></ArticleIdList></Reference><Reference><Citation>Cilia R, Rossi C, Frosini D, et al. Dopamine transporter SPECT imaging in Corticobasal Syndrome. PLoS One. 2011;6:e18301. doi: 10.1371/journal.pone.0018301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0018301</ArticleId><ArticleId IdType="pmc">PMC3085517</ArticleId><ArticleId IdType="pubmed">21559307</ArticleId></ArticleIdList></Reference><Reference><Citation>Frosini D, Ceravolo R, Tosetti M, Bonuccelli U, Cosottini M. Nigral involvement in atypical parkinsonisms: evidence from a pilot study with ultra-high field MRI. J Neural Transm. 2016;123:509&#x2013;513. doi: 10.1007/s00702-016-1529-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-016-1529-2</ArticleId><ArticleId IdType="pubmed">26943945</ArticleId></ArticleIdList></Reference><Reference><Citation>Fearnley JM, Lees AJ. Ageing and Parkinson&#x2019;s disease: substantia nigra regional selectivity. Brain. 1991;114:2283&#x2013;2301. doi: 10.1093/brain/114.5.2283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/114.5.2283</ArticleId><ArticleId IdType="pubmed">1933245</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavese N, Tai YF. Nigrosome imaging and neuromelanin sensitive MRI in diagnostic evaluation of Parkinsonism. Mov Disord Clin Pract. 2018;5:131&#x2013;140. doi: 10.1002/mdc3.12590.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mdc3.12590</ArticleId><ArticleId IdType="pmc">PMC6174398</ArticleId><ArticleId IdType="pubmed">30363419</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarow C, Lyness SA, Mortimer JA, Chui HC. Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Arch Neurol. 2003;60:337&#x2013;341. doi: 10.1001/archneur.60.3.337.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.60.3.337</ArticleId><ArticleId IdType="pubmed">12633144</ArticleId></ArticleIdList></Reference><Reference><Citation>Gesi M, Soldani P, Giorgi FS, Santinami A, Bonaccorsi I, Fornai F. The role of the locus coeruleus in the development of Parkinson&#x2019;s disease. Neurosci Biobehav Rev. 2000;24:655&#x2013;668. doi: 10.1016/S0149-7634(00)00028-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0149-7634(00)00028-2</ArticleId><ArticleId IdType="pubmed">10940440</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohtsuka C, Sasaki M, Konno K, et al. Changes in substantia nigra and locus coeruleus in patients with early-stage Parkinson&#x2019;s disease using neuromelanin-sensitive MR imaging. Neurosci Lett. 2013;541:93&#x2013;98. doi: 10.1016/j.neulet.2013.02.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2013.02.012</ArticleId><ArticleId IdType="pubmed">23428505</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki M, Shibata E, Tohyama K, et al. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson&#x2019;s disease. Neuroreport. 2006;17:1215&#x2013;1218. doi: 10.1097/01.wnr.0000227984.84927.a7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.wnr.0000227984.84927.a7</ArticleId><ArticleId IdType="pubmed">16837857</ArticleId></ArticleIdList></Reference><Reference><Citation>Tona K-D, van Osch MJP, Nieuwenhuis S, Keuken MC. Quantifying the contrast of the human locus coeruleus in vivo at 7 Tesla MRI. PLoS One. 2019;14:e0209842. doi: 10.1371/journal.pone.0209842.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0209842</ArticleId><ArticleId IdType="pmc">PMC6364884</ArticleId><ArticleId IdType="pubmed">30726221</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye R, O&#x2019;Callaghan C, Rua C, et al. Annual Meeting of the Organization for Human Brain Mapping. 2019. Imaging the locus coeruleus in Parkinson&#x2019;s disease with ultra-high 7 T MRI; p. W272.</Citation></Reference><Reference><Citation>Tk&#xe1;&#x10d; I, Gruetter R. Methodology of 1H NMR spectroscopy of the human brain at very high magnetic fields. Appl Magn Reson. 2005;29:139&#x2013;157. doi: 10.1007/BF03166960.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03166960</ArticleId><ArticleId IdType="pmc">PMC2825674</ArticleId><ArticleId IdType="pubmed">20179773</ArticleId></ArticleIdList></Reference><Reference><Citation>Emir UE, Auerbach EJ, Van De Moortele P-F, et al. Regional neurochemical profiles in the human brain measured by 1H MRS at 7 T using local B1 shimming. NMR Biomed. 2012;25:152&#x2013;160. doi: 10.1002/nbm.1727.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nbm.1727</ArticleId><ArticleId IdType="pmc">PMC3197892</ArticleId><ArticleId IdType="pubmed">21766380</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe H, Fukatsu H, Katsuno M, et al. Multiple regional 1H-MR spectroscopy in multiple system atrophy: NAA/Cr reduction in pontine base as a valuable diagnostic marker. J Neurol Neurosurg Psychiatry. 2004;75:103&#x2013;109.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1757481</ArticleId><ArticleId IdType="pubmed">14707317</ArticleId></ArticleIdList></Reference><Reference><Citation>Emir UE, Tuite PJ, &#xd6;z G. Elevated pontine and putamenal gaba levels in mild-moderate parkinson disease detected by 7 tesla proton mrs. PLoS One. 2012;7:e30918. doi: 10.1371/journal.pone.0030918.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0030918</ArticleId><ArticleId IdType="pmc">PMC3266292</ArticleId><ArticleId IdType="pubmed">22295119</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Del Tredici K, R&#xfc;b U, et al. Staging of brain pathology related to sporadic Parkinson&#x2019;s disease. Neurobiol Aging. 2003;24:197&#x2013;211. doi: 10.1016/S0197-4580(02)00065-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0197-4580(02)00065-9</ArticleId><ArticleId IdType="pubmed">12498954</ArticleId></ArticleIdList></Reference><Reference><Citation>Abosch A, Yacoub E, Ugurbil K, Harel N. An assessment of current brain targets for deep brain stimulation surgery with susceptibility-weighted imaging at 7 Tesla. Neurosurgery. 2010;67:1745&#x2013;1756. doi: 10.1227/NEU.0b013e3181f74105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1227/NEU.0b013e3181f74105</ArticleId><ArticleId IdType="pmc">PMC3124849</ArticleId><ArticleId IdType="pubmed">21107206</ArticleId></ArticleIdList></Reference><Reference><Citation>Duchin Y, Abosch A, Yacoub E, Sapiro G, Harel N. Feasibility of using ultra-high field (7 T) MRI for clinical surgical targeting. PLoS One. 2012;7:e37328. doi: 10.1371/journal.pone.0037328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0037328</ArticleId><ArticleId IdType="pmc">PMC3355118</ArticleId><ArticleId IdType="pubmed">22615980</ArticleId></ArticleIdList></Reference><Reference><Citation>Patriat R, Cooper SE, Duchin Y, et al. Individualized tractography-based parcellation of the globus pallidus pars interna using 7 T MRI in movement disorder patients prior to DBS surgery. Neuroimage. 2018;178:198&#x2013;209. doi: 10.1016/j.neuroimage.2018.05.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2018.05.048</ArticleId><ArticleId IdType="pmc">PMC6046264</ArticleId><ArticleId IdType="pubmed">29787868</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamir RR, Duchin Y, Kim J, et al. Microelectrode recordings validate the clinical visualization of subthalamic-nucleus based on 7 T magnetic resonance imaging and machine learning for deep brain stimulation surgery. Neurosurgery. 2019;84:749&#x2013;757. doi: 10.1093/neuros/nyy212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/neuros/nyy212</ArticleId><ArticleId IdType="pmc">PMC6500885</ArticleId><ArticleId IdType="pubmed">29800386</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Calvo A, Moglia C, et al. Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry. 2011;82:740&#x2013;746. doi: 10.1136/jnnp.2010.235952.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.235952</ArticleId><ArticleId IdType="pubmed">21402743</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan MC, Vucic S, Cheah BC, et al. Amyotrophic lateral sclerosis. Lancet. 2011;377:942&#x2013;955. doi: 10.1016/S0140-6736(10)61156-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Montuschi A, Iazzolino B, Calvo A, et al. Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy. J Neurol Neurosurg Psychiatry. 2015;86:168&#x2013;173. doi: 10.1136/jnnp-2013-307223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2013-307223</ArticleId><ArticleId IdType="pubmed">24769471</ArticleId></ArticleIdList></Reference><Reference><Citation>Riancho J, Bosque-Varela P, Perez-Pereda S, Povedano M, de Muna&#xed;n AL, Santurtun A. The increasing importance of environmental conditions in amyotrophic lateral sclerosis. Int J Biometeorol. 2018;62:1361&#x2013;1374. doi: 10.1007/s00484-018-1550-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00484-018-1550-2</ArticleId><ArticleId IdType="pubmed">29713861</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcia P, Tauber C, Vercoullie J, et al. Molecular imaging of microglial activation in amyotrophic lateral sclerosis. PLoS One. 2012;7:e52941. doi: 10.1371/journal.pone.0052941.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0052941</ArticleId><ArticleId IdType="pmc">PMC3534121</ArticleId><ArticleId IdType="pubmed">23300829</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Bowser R, Bruijn L, et al. Mechanisms, models and biomarkers in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Front Degener. 2013;14:19&#x2013;32. doi: 10.3109/21678421.2013.778554.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.778554</ArticleId><ArticleId IdType="pmc">PMC4284067</ArticleId><ArticleId IdType="pubmed">23678877</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Wang F. Role of neuroinflammation in amyotrophic lateral sclerosis: cellular mechanisms and therapeutic implications. Front Immunol. 2017;8:1005. doi: 10.3389/fimmu.2017.01005.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01005</ArticleId><ArticleId IdType="pmc">PMC5567007</ArticleId><ArticleId IdType="pubmed">28871262</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamata T, Akiyama H, Yamada T, McGeer PL. Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am J Pathol. 1992;140:691&#x2013;707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1886170</ArticleId><ArticleId IdType="pubmed">1347673</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijesekera LC, Leigh PN. Amyotrophic lateral sclerosis. Orphanet J Rare Dis. 2009;4:3. doi: 10.1186/1750-1172-4-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1172-4-3</ArticleId><ArticleId IdType="pmc">PMC2656493</ArticleId><ArticleId IdType="pubmed">19192301</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippi M, Agosta F, Abrahams S, et al. EFNS guidelines on the use of neuroimaging in the management of motor neuron diseases. Eur J Neurol. 2010;17:526&#x2013;e20. doi: 10.1111/j.1468-1331.2010.02951.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2010.02951.x</ArticleId><ArticleId IdType="pmc">PMC3154636</ArticleId><ArticleId IdType="pubmed">20136647</ArticleId></ArticleIdList></Reference><Reference><Citation>Atkinson AJ, Colburn WA, DeGruttola VG, et al. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69:89&#x2013;95. doi: 10.1067/mcp.2001.113989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mcp.2001.113989</ArticleId><ArticleId IdType="pubmed">11240971</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F, Spinelli EG, Filippi M. Neuroimaging in amyotrophic lateral sclerosis: current and emerging uses. Expert Rev Neurother. 2018;18:395&#x2013;406. doi: 10.1080/14737175.2018.1463160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14737175.2018.1463160</ArticleId><ArticleId IdType="pubmed">29630421</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosottini M, Donatelli G, Costagli M, et al. High-resolution 7 T MR imaging of the motor cortex in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol. 2016;37:455&#x2013;461. doi: 10.3174/ajnr.A4562.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A4562</ArticleId><ArticleId IdType="pmc">PMC7960124</ArticleId><ArticleId IdType="pubmed">26680464</ArticleId></ArticleIdList></Reference><Reference><Citation>Oba H, Araki T, Ohtomo K, et al. Amyotrophic lateral sclerosis: T2 shortening in motor cortex at MR imaging. Radiology. 1993;189:843&#x2013;846. doi: 10.1148/radiology.189.3.8234713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiology.189.3.8234713</ArticleId><ArticleId IdType="pubmed">8234713</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishikawa K, Nagura H, Yokota T, Yamanouchi H. Signal loss in the motor cortex on magnetic resonance images in amyotrophic lateral sclerosis. Ann Neurol. 1993;33:218&#x2013;222. doi: 10.1002/ana.410330214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410330214</ArticleId><ArticleId IdType="pubmed">8434885</ArticleId></ArticleIdList></Reference><Reference><Citation>Ignjatovi&#x107; A, Stevi&#x107; Z, Lavrni&#x107; S, Dakovi&#x107; M, Ba&#x10d;i&#x107; G. Brain iron MRI: a biomarker for amyotrophic lateral sclerosis. J Magn Reson Imaging. 2013;38:1472&#x2013;1479. doi: 10.1002/jmri.24121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmri.24121</ArticleId><ArticleId IdType="pubmed">23564606</ArticleId></ArticleIdList></Reference><Reference><Citation>Adachi Y, Sato N, Saito Y, et al. Usefulness of SWI for the detection of iron in the motor cortex in amyotrophic lateral sclerosis. J Neuroimaging. 2015;25:443&#x2013;451. doi: 10.1111/jon.12127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jon.12127</ArticleId><ArticleId IdType="pubmed">24888543</ArticleId></ArticleIdList></Reference><Reference><Citation>Donatelli G, Retico A, Ienco EC, et al. Semiautomated evaluation of the primary motor cortex in patients with amyotrophic lateral sclerosis at 3 T. AJNR Am J Neuroradiol. 2018;39:63&#x2013;69. doi: 10.3174/ajnr.A5423.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A5423</ArticleId><ArticleId IdType="pmc">PMC7410679</ArticleId><ArticleId IdType="pubmed">29122765</ArticleId></ArticleIdList></Reference><Reference><Citation>Obusez EC, Lowe M, Oh SH, et al. 7 T MR of intracranial pathology: preliminary observations and comparisons to 3 T and 1.5T. Neuroimage. 2018;168:459&#x2013;476. doi: 10.1016/j.neuroimage.2016.11.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2016.11.030</ArticleId><ArticleId IdType="pubmed">27915116</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukunaga M, Li TQ, Van Gelderen P, et al. Layer-specific variation of iron content in cerebral cortex as a source of MRI contrast. Proc Natl Acad Sci U S A. 2010;107:3834&#x2013;3839. doi: 10.1073/pnas.0911177107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0911177107</ArticleId><ArticleId IdType="pmc">PMC2840419</ArticleId><ArticleId IdType="pubmed">20133720</ArticleId></ArticleIdList></Reference><Reference><Citation>Costagli M, Donatelli G, Biagi L, et al. Magnetic susceptibility in the deep layers of the primary motor cortex in amyotrophic lateral sclerosis. Neuroimage Clin. 2016;12:965&#x2013;969. doi: 10.1016/j.nicl.2016.04.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2016.04.011</ArticleId><ArticleId IdType="pmc">PMC5153607</ArticleId><ArticleId IdType="pubmed">27995062</ArticleId></ArticleIdList></Reference><Reference><Citation>Pallebage-Gamarallage M, Foxley S, Menke RAL, et al. Dissecting the pathobiology of altered MRI signal in amyotrophic lateral sclerosis: a post mortem whole brain sampling strategy for the integration of ultra-high-field MRI and quantitative neuropathology. BMC Neurosci. 2018;19:1&#x2013;24. doi: 10.1186/s12868-018-0416-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12868-018-0416-1</ArticleId><ArticleId IdType="pmc">PMC5848544</ArticleId><ArticleId IdType="pubmed">29529995</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweitzer AD, Liu T, Gupta A, et al. Quantitative susceptibility mapping of the motor cortex in amyotrophic lateral sclerosis and primary lateral sclerosis. AJR Am J Roentgenol. 2015;204:1086&#x2013;1092. doi: 10.2214/AJR.14.13459.</Citation><ArticleIdList><ArticleId IdType="doi">10.2214/AJR.14.13459</ArticleId><ArticleId IdType="pmc">PMC4889122</ArticleId><ArticleId IdType="pubmed">25905946</ArticleId></ArticleIdList></Reference><Reference><Citation>Walhout R, Westeneng HJ, Verstraete E, et al. Cortical thickness in ALS: towards a marker for upper motor neuron involvement. J Neurol Neurosurg Psychiatry. 2015;86:288&#x2013;294. doi: 10.1136/jnnp-2013-306839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2013-306839</ArticleId><ArticleId IdType="pubmed">25121571</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta-Cabronero J, Machts J, Schreiber S, et al. Quantitative susceptibility MRI to detect brain iron in amyotrophic lateral sclerosis. Radiology. 2018;289:195&#x2013;203. doi: 10.1148/radiol.2018180112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2018180112</ArticleId><ArticleId IdType="pmc">PMC6166868</ArticleId><ArticleId IdType="pubmed">30040038</ArticleId></ArticleIdList></Reference><Reference><Citation>Donatelli G, Caldarazzo Ienco E, Costagli M, et al. MRI cortical feature of bulbar impairment in patients with amyotrophic lateral sclerosis. Neuroimage Clin. 2019;24:101934. doi: 10.1016/j.nicl.2019.101934.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2019.101934</ArticleId><ArticleId IdType="pmc">PMC6698695</ArticleId><ArticleId IdType="pubmed">31377555</ArticleId></ArticleIdList></Reference><Reference><Citation>Tk&#xe1;&#x10d; I, &#xd6;z G, Adriany G, U&#x11f;urbil K, Gruetter R. In vivo 1H NMR spectroscopy of the human brain at high magnetic fields: Metabolite quantification at 4T vs. 7 T. Magn Reson Med. 2009;62:868&#x2013;879. doi: 10.1002/mrm.22086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.22086</ArticleId><ArticleId IdType="pmc">PMC2843548</ArticleId><ArticleId IdType="pubmed">19591201</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebisu T, Rooney WD, Graham SH, Weiner MW, Maudsley AA. N-acetylaspartate as an in vivo marker of neuronal viability in kainate- induced status epilepticus: 1H magnetic resonance spectroscopic imaging. J Cereb Blood Flow Metab. 1994;14:373&#x2013;382. doi: 10.1038/jcbfm.1994.48.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jcbfm.1994.48</ArticleId><ArticleId IdType="pubmed">8163579</ArticleId></ArticleIdList></Reference><Reference><Citation>Brand A, Richter-Landsberg C, Leibfritz D. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci. 1993;15:289&#x2013;298. doi: 10.1159/000111347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000111347</ArticleId><ArticleId IdType="pubmed">7805581</ArticleId></ArticleIdList></Reference><Reference><Citation>Atassi N, Xu M, Triantafyllou C, et al. Ultra high-field (7 Tesla) magnetic resonance spectroscopy in Amyotrophic Lateral Sclerosis. PLoS One. 2017;12:e0177680. doi: 10.1371/journal.pone.0177680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0177680</ArticleId><ArticleId IdType="pmc">PMC5428977</ArticleId><ArticleId IdType="pubmed">28498852</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheong I, Marja&#x144;ska M, Deelchand DK, Eberly LE, Walk D, &#xd6;z G. Ultra-high field proton MR spectroscopy in early-stage amyotrophic lateral sclerosis. Neurochem Res. 2017;42:1833&#x2013;1844. doi: 10.1007/s11064-017-2248-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-017-2248-2</ArticleId><ArticleId IdType="pmc">PMC5488866</ArticleId><ArticleId IdType="pubmed">28367604</ArticleId></ArticleIdList></Reference><Reference><Citation>Doble A. The pharmacology and mechanism of action of riluzole. Neurology. 1996;47:233S&#x2013;241S. doi: 10.1212/WNL.47.6_Suppl_4.233S.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.47.6_Suppl_4.233S</ArticleId><ArticleId IdType="pubmed">8959995</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantz J, Laudenbach V, Lecharny JB, Henzel D, Desmonts JM. Riluzole, a novel antiglutamate, blocks GABA uptake by striatal synaptosomes. Eur J Pharmacol. 1994;257:R7&#x2013;R8. doi: 10.1016/0014-2999(94)90716-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0014-2999(94)90716-1</ArticleId><ArticleId IdType="pubmed">8082687</ArticleId></ArticleIdList></Reference><Reference><Citation>Danbolt NC. Glutamate uptake. Prog Neurobiol. 2001;65:1&#x2013;105. doi: 10.1016/S0301-0082(00)00067-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0301-0082(00)00067-8</ArticleId><ArticleId IdType="pubmed">11369436</ArticleId></ArticleIdList></Reference><Reference><Citation>Majounie E, Renton AE, Mok K, et al. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol. 2012;11:323&#x2013;330. doi: 10.1016/S1474-4422(12)70043-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(12)70043-1</ArticleId><ArticleId IdType="pmc">PMC3322422</ArticleId><ArticleId IdType="pubmed">22406228</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, Mackenzie IR, Boeve BF, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Westeneng H-J, Wismans C, Nitert AD, et al. Annual Meeting of the International Society for Magnetic Resonance in Medicine. 2017. Metabolic differences between asymptomatic C9orf72 carriers and non-carriers assessed by brain 7 T MRSI; p. 0028.</Citation></Reference><Reference><Citation>Donatelli G, Westeneng H-J, van Veenhuijzen K, et al. Joint Annual Meeting ISMRM-ESMRMB. 2018. 31P MRSI of asymptomatic C9orf72 carriers and non-carriers at 7 Tesla; p. 0583.</Citation></Reference><Reference><Citation>Agosta F, Chi&#xf2; A, Cosottini M, et al. The present and the future of neuroimaging in amyotrophic lateral sclerosis. AJR Am J Neuroradiol. 2010;31:1769&#x2013;1777. doi: 10.3174/ajnr.A2043.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A2043</ArticleId><ArticleId IdType="pmc">PMC7964007</ArticleId><ArticleId IdType="pubmed">20360339</ArticleId></ArticleIdList></Reference><Reference><Citation>Verstraete E, Polders DL, Mandl RCW, et al. Multimodal tract-based analysis in ALS patients at 7 T: a specific white matter profile? Amyotroph Lateral Scler Front Degener. 2014;15:84&#x2013;92. doi: 10.3109/21678421.2013.844168.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.844168</ArticleId><ArticleId IdType="pubmed">24325276</ArticleId></ArticleIdList></Reference><Reference><Citation>Barry RL, Vannesjo SJ, By S, Gore JC, Smith SA. Spinal cord MRI at 7 T. Neuroimage. 2018;168:437&#x2013;451. doi: 10.1016/j.neuroimage.2017.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2017.07.003</ArticleId><ArticleId IdType="pmc">PMC5894871</ArticleId><ArticleId IdType="pubmed">28684332</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigmund EE, Suero GA, Hu C, et al. High-resolution human cervical spinal cord imaging at 7 T. NMR Biomed. 2012;25:891&#x2013;899. doi: 10.1002/nbm.1809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nbm.1809</ArticleId><ArticleId IdType="pmc">PMC3377161</ArticleId><ArticleId IdType="pubmed">22183956</ArticleId></ArticleIdList></Reference><Reference><Citation>Henning A, Koning W, Fuchs A, et al. 1H MRS in the human spinal cord at 7 T using a dielectric waveguide transmitter, RF shimming and a high density receive array. NMR Biomed. 2016;29:1231&#x2013;1239. doi: 10.1002/nbm.3541.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nbm.3541</ArticleId><ArticleId IdType="pubmed">27191947</ArticleId></ArticleIdList></Reference><Reference><Citation>Kogan F, Singh A, Debrosse C, et al. Imaging of glutamate in the spinal cord using GluCEST. Neuroimage. 2013;77:262&#x2013;267. doi: 10.1016/j.neuroimage.2013.03.072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2013.03.072</ArticleId><ArticleId IdType="pmc">PMC3804007</ArticleId><ArticleId IdType="pubmed">23583425</ArticleId></ArticleIdList></Reference><Reference><Citation>Massire A, Rasoanandrianina H, Taso M, et al. Feasibility of single-shot multi-level multi-angle diffusion tensor imaging of the human cervical spinal cord at 7 T. Magn Reson Med. 2018;80:947&#x2013;957. doi: 10.1002/mrm.27087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.27087</ArticleId><ArticleId IdType="pubmed">29369451</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen-Adad J, Zhao W, Keil B, et al. 7-T MRI of the spinal cord can detect lateral corticospinal tract abnormality in amyotrophic lateral sclerosis. Muscle Nerve. 2013;47:760&#x2013;762. doi: 10.1002/mus.23720.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.23720</ArticleId><ArticleId IdType="pubmed">23553571</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>